Clinical Trials Browser

Phase 2 × OTHER × DMMR Colorectal Cancer × Clear all

NCT04301557 2024-04-23

PD1 Antibody Toripalimab and Chemoradiotherapy for dMMR/MSI-H Locally Advanced Colorectal Cancer

Phase 2 Active not recruiting

GastrointestinalOther solid neoplasm

DMMR Colorectal Cancer

NCT06262581 2024-02-16

Neoadjuvant Tisleizumab(BGB-A317) for dMMR/MSI-H Non-late Stage CRC Patients Before Surgery

Phase 2 Unknown

GastrointestinalOther solid neoplasm

DMMR Colorectal Cancer